Symbio Pharmaceuticals Limited Financial Overview
Symbio Pharmaceuticals Limited's market cap is currently ¥5.25B. The company's EPS TTM is ¥-24.11; its P/E ratio is -0.98; Symbio Pharmaceuticals Limited is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
